ProfileGDS4718 / 232731_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 36% 30% 27% 28% 33% 36% 37% 26% 27% 30% 28% 27% 32% 31% 38% 32% 29% 36% 34% 46% 27% 29% 35% 27% 33% 33% 31% 55% 32% 29% 38% 29% 30% 26% 31% 28% 32% 22% 26% 25% 25% 36% 30% 38% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8119336
GSM549102patient 115, normal, homogenized [OPG study]4.5770430
GSM549104patient 119, normal, homogenized [OPG study]4.3891527
GSM549108patient 138, normal, homogenized [OPG study]4.4935528
GSM549119patient 077, normal, homogenized [OPG study]4.6649433
GSM549133patient 032, cancer, homogenized [OPG study]4.7575936
GSM549139patient 042, cancer, homogenized [OPG study]4.8214637
GSM549099patient 107, normal, homogenized [OPG study]4.4036126
GSM549109patient 139, normal, homogenized [OPG study]4.4385927
GSM549110patient 046, normal, homogenized [OPG study]4.5420930
GSM549114patient 063, normal, homogenized [OPG study]4.4264228
GSM549122patient 082, normal, homogenized [OPG study]4.4177227
GSM549134patient 033, cancer, homogenized [OPG study]4.6321432
GSM549136patient 036, cancer, homogenized [OPG study]4.5185731
GSM549140patient 044, cancer, homogenized [OPG study]4.8639138
GSM549111patient 047, normal, homogenized [OPG study]4.609532
GSM549113patient 057, normal, homogenized [OPG study]4.4408729
GSM549132patient 031, cancer, homogenized [OPG study]4.8075236
GSM549137patient 038, cancer, homogenized [OPG study]4.6900134
GSM549142patient 047, cancer, homogenized [OPG study]5.4118546
GSM549100patient 110, normal, homogenized [OPG study]4.4497927
GSM549107patient 135, normal, homogenized [OPG study]4.4910529
GSM549115patient 068, normal, homogenized [OPG study]4.696635
GSM549116patient 072, normal, homogenized [OPG study]4.3971327
GSM549120patient 078, normal, homogenized [OPG study]4.6562733
GSM549131patient 030, cancer, homogenized [OPG study]4.6234533
GSM549118patient 074, normal, homogenized [OPG study]4.5883831
GSM549129patient 027, cancer, homogenized [OPG study]5.8055455
GSM549123patient 088, normal, homogenized [OPG study]4.6035332
GSM549124patient 006, cancer, homogenized [OPG study]4.5278829
GSM549126patient 015, cancer, homogenized [OPG study]4.8803438
GSM549128patient 025, cancer, homogenized [OPG study]4.4645929
GSM549103patient 117, normal, homogenized [OPG study]4.5900130
GSM549117patient 073, normal, homogenized [OPG study]4.3681926
GSM549138patient 041, cancer, homogenized [OPG study]4.57631
GSM549141patient 045, cancer, homogenized [OPG study]4.3895228
GSM549130patient 028, cancer, homogenized [OPG study]4.635632
GSM549101patient 111, normal, homogenized [OPG study]4.224822
GSM549105patient 128, normal, homogenized [OPG study]4.404226
GSM549106patient 134, normal, homogenized [OPG study]4.2847625
GSM549112patient 048, normal, homogenized [OPG study]4.3400725
GSM549125patient 011, cancer, homogenized [OPG study]4.8161236
GSM549127patient 024, cancer, homogenized [OPG study]4.5169530
GSM549135patient 035, cancer, homogenized [OPG study]4.8583338